Is CDKN2A p.Ala102fs (c.303_304insC) pathogenic?

CDKN2A p.Ala102fs (c.303304insC) is classified Pathogenic/Likely pathogenic in CDKN2A (ClinVar, Multiple submitters, 2 submitters; last evaluated 2021-12-25). Absent from gnomAD; Associated with familial melanoma.

What condition is associated with CDKN2A p.Ala102fs (c.303_304insC)?

CDKN2A p.Ala102fs (c.303_304insC) is associated with familial melanoma (ClinVar).

How common is CDKN2A p.Ala102fs (c.303_304insC) in the general population?

CDKN2A p.Ala102fs (c.303_304insC) is absent from gnomAD (gnomAD).

How is Familial melanoma inherited?

Typically Autosomal dominant, Multigenic/multifactorial (Orphanet). A genetic counselor can assess individual risk for a family.

CDKN2A p.Ala102fs

c.303_304insC · rs2131094090 · VCV2060012

Pathogenic/Likely pathogenic Multiple submitters

Classification

Pathogenic/Likely pathogenic

ClinVar

Review

Multiple submitters ★★☆☆

ClinVar · 2 submitters

Consequence

frameshift

predicted LoF

gnomAD v4.1

Not reported

no gnomAD frequency available for this variant

Conditions

familial melanoma

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Consequence	frameshift	predicted loss-of-function in a haploinsufficient gene (ClinGen)
NMD	predicted	premature termination codon in exon 2 of 3
Splicing
SpliceAI	—	not assessed · substitutions only
Constraint at this position
Conservation	phyloP 7.5	GERP 2, phastCons 1

Predicted loss-of-function is descriptive, not an applied PVS1 code.

Population frequency

dbSNP / gnomAD

No gnomAD frequency available for this variant. This is missing data, not an absence: the variant may or may not be present in gnomAD. Rarity (ACMG PM2) and BA1/BS1 cannot be assessed for it.

Variant & gene context

Gene: CDKN2A
Protein: p.Ala102fs
Coding: c.303_304insC
MANE Select: NM_000077
dbSNP: rs2131094090
Type: Insertion
Location: chr9:21971055 (GRCh38)
Gene constraint: LOEUF 0.791 · pLI 0.62 · ClinGen HI 3/3 (gnomAD)
Structure: AlphaFold pLDDT 77.02 · 5 PDB
Residue 102: a UniProt-annotated variant site (found in seminoma and medulloblastoma tissues from li-fraumeni syndrome patients carrying a mutation in tp53; somatic mutation); a UniProt-annotated variant site (in); the 'disordered' region

Full CDKN2A gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

familial melanoma — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Familial melanoma (Orphanet):

Inheritance: Autosomal dominant, Multigenic/multifactorial
Onset: Adult
Prevalence: 1-9 / 100 000 (Europe)

Similar variants

CDKN2A p.Ala102Thr Uncertain significance ★★ ⚠ same residue
CDKN2A p.Ala102Val Uncertain significance ★★ ⚠ same residue
CDKN2A p.Ala102Glu Conflicting classifications of pathogenicity ★ ⚠ same residue
CDKN2A p.Ala102Ser Uncertain significance ★ ⚠ same residue
CDKN2A p.Tyr44Ter Pathogenic ★★ same condition
CDKN2A p.Val43fs Pathogenic ★ same condition
CDKN2A p.Ala102= Uncertain significance ★ same residue
CDKN2A p.Ala102Leu Uncertain significance ★ same residue

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cdkn2a-p-ala102fs (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown